Hyaluronic acid-based prodrug nanomedicines for enhanced tumor targeting and therapy: A review

R Zhang, X Zhao, A Jia, C Wang, H Jiang - International Journal of …, 2023 - Elsevier
Hyaluronic acid (HA) represents a natural polysaccharide which has attracted significant
attention owing to its improved tumor targeting capacity, enzyme degradation capacity, and …

Recent progresses in the development of hyaluronic acid-based nanosystems for tumor-targeted drug delivery and cancer imaging

HJ Cho - Journal of pharmaceutical investigation, 2020 - Springer
Background Hyaluronic acid (HA) has been widely used as one of major components of
nanocarriers for cancer imaging and therapy. HA possesses hydrophilic and anionic …

[HTML][HTML] Development and application of hyaluronic acid in tumor targeting drug delivery

Z Luo, Y Dai, H Gao - Acta Pharmaceutica Sinica B, 2019 - Elsevier
Hyaluronic acid (HA) is a natural polysaccharide that has gained much attention due to its
biocompatibility, enzyme degradation capacity and active tumor targeting capacity. Its …

A potential carrier for anti-tumor targeted delivery-hyaluronic acid nanoparticles

J Cai, J Fu, R Li, F Zhang, G Ling, P Zhang - Carbohydrate polymers, 2019 - Elsevier
In recent years, biomacromolecules have been widely used in anti-tumor delivery systems
due to the biocompatibility and biodegradability. However, their applications are limited due …

Advances in hyaluronic acid-based drug delivery systems

Y Jiao, X Pang, G Zhai - Current Drug Targets, 2016 - ingentaconnect.com
Hyaluronic acid (HA) is a relatively new polymer for the construction of drug delivery
systems. CD44 and the receptor for HA-mediated motility play a key role in vivo for the …

[HTML][HTML] Hyaluronic acid-coated nanomedicine for targeted cancer therapy

K Kim, H Choi, ES Choi, MH Park, JH Ryu - Pharmaceutics, 2019 - mdpi.com
Hyaluronic acid (HA) has been widely investigated in cancer therapy due to its excellent
characteristics. HA, which is a linear anionic polymer, has biocompatibility, biodegradability …

Recent advances in hyaluronic acid-based nanomedicines: Preparation and application in cancer therapy

X Hou, D Zhong, H Chen, Z Gu, Q Gong, X Ma… - Carbohydrate …, 2022 - Elsevier
Rapid development of stimuli-responsive drug delivery systems (DDSs) for tumor therapy
has raised increasing interest in recent decades, and many nanomedicines are prepared to …

Development and mechanistic insight into enhanced cytotoxic potential of hyaluronic acid conjugated nanoparticles in CD44 overexpressing cancer cells

A Saneja, D Nayak, M Srinivas, A Kumar… - European Journal of …, 2017 - Elsevier
The overexpression of CD44 in cancer cells reroutes number of oncogenic pathways
including the central Pi3K/Akt/NF-kB pathway leading to cancer progression and …

Recent developments in hyaluronic acid-based nanomedicine for targeted cancer treatment

NV Rao, HY Yoon, HS Han, H Ko, S Son… - Expert opinion on …, 2016 - Taylor & Francis
Introduction: Hyaluronic acid (HA) has emerged as a promising applicant for the tumor-
targeted delivery of various therapeutic agents. Because of its biocompatibility …

[HTML][HTML] Hyaluronic acid-based nanocarriers for anticancer drug delivery

CP Fu, XY Cai, SL Chen, HW Yu, Y Fang, XC Feng… - Polymers, 2023 - mdpi.com
Hyaluronic acid (HA), a main component of the extracellular matrix, is widely utilized to
deliver anticancer drugs due to its biocompatibility, biodegradability, non-toxicity, non …